Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin 750 mg vs ceftriaxone + macrolide in community-acquired pneumonia
KCT0000374Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of levofloxacin in community-acquired pneumonia (CAP) (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Started May 2010; status: completed.
02
Drugs
levofloxacin
03
Conditions
community-acquired pneumonia (CAP)
Beyond the preview
Go deeper on KCT0000374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000374.